MedPath

CETIC-I (CEra Traction Improves Cervical Kyphosis -I)

Not Applicable
Not yet recruiting
Conditions
Kyphosis
Cervical Lordosis
Cervical Kyphosis
Interventions
Device: CGM MB-1701 device treatment
Device: CGM MB-1701 Sham device treatment
Registration Number
NCT05469295
Lead Sponsor
Ceragem Clinical Inc.
Brief Summary

The study is a Prospective, Randomized, Single-blinded, Sham device controlled, Parallel Treatment Grouped, Multi-center, Exploratory Clinical Trial to Evaluate Improvement of Cervical Lordosis and Safety of CGM MB-1701 (Spinal warm massage device, Ceragem Master V6) in Subjects with Cervical Kyphosis and Posterior Neck Pain.

Detailed Description

The Cervical Kyphosis are also commonly referred to as "turtle neck syndrome." It refers to the deformation of the neck bone into an inverted C-shape due to abnormalities or degenerative changes, and it is named to mean that the neck is bent like a turtle.

This device, Ceragem Master V6 (CGM MB-1701), has been certified as a combination of a personal warmer that can be used to relieve muscle pain by applying constant heat to the human body and a medical vibrator of a device that applies physical energy (vibration, shock, pressure, etc.). Also, the device got approval for use with intermittent pneumatic compression and electrically-powered orthopedics traction.

The primary purpose of this clinical trial is to confirm the temporary cervical lordosis angle improvement (height) in subjects with cervical kyphosis through the combined function of the test device.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Adult male and female subjects who have voluntarily decided to participate and agreed in writing after being briefed on the characteristics of this clinical trial and medical device
  2. Subjects with cervical kyphosis angle between cervical lordosis 20 degrees and cervical kyphosis 5 degrees.
  3. BMI betweeen 18.5 and 30
  4. Chronic neck pain NRS 4 or higher lasting more than 3 months
Exclusion Criteria
  1. Secondary spondylosis
  2. A tumor of the spine
  3. Inflammatory spondylitis
  4. Myelopathy
  5. Multiple adjacent radiculopathies and others

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CGM_MB_1701 treatmentCGM MB-1701 device treatmentSubjects will be treated with the study device for about 36 minutes.
Sham (CGM MB1701C) treamentCGM MB-1701 Sham device treatmentSubjects will be treated with the Sham device for about 36 minutes.
Primary Outcome Measures
NameTimeMethod
Mean change of cervical lordosisup to 16 weeks

Mean change of cervical lordosis using posterior tangent method of Harrison measured by cervical lateral radiography at EOT (End of Trial) compared to baseline.

Secondary Outcome Measures
NameTimeMethod
Cervical vestibular angle increase more than 10 degreesup to 16 weeks

The fraction of subjects whose cervical vestibular angle measured by the posterior tangent method of Harrison at each time of evaluation increased by more than 10 degrees compared to the baseline

Anteroposterior (T1) slope average changeup to 16 weeks

Average change in cervical anteroposterior (T1) slope measured by cervical lateral radiography at each evaluation compare to the baseline

Change of cervical lordosis at 2nd interim analysisup to 16 weeks

Change of the cervical lordosis (posterior tangent method of Harrison) measured by cervical lateral radiography at the 2nd interim visit compared to baseline.

© Copyright 2025. All Rights Reserved by MedPath